<ARTICLE> 5
<CIK> 0000830656
<NAME> BOSTON BIOMEDICA

                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                         179,962
<SECURITIES>                                         0
<RECEIVABLES>                                6,931,363
<ALLOWANCES>                                 (745,172)
<INVENTORY>                                  7,085,843
<CURRENT-ASSETS>                            15,120,376
<PP&E>                                      13,524,994
<DEPRECIATION>                             (5,410,327)
<TOTAL-ASSETS>                              26,128,663
<CURRENT-LIABILITIES>                       12,366,282
<BONDS>                                        459,699
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        54,661
<OTHER-SE>                                  13,248,021
<TOTAL-LIABILITY-AND-EQUITY>                26,128,663
<SALES>                                      2,597,082
<TOTAL-REVENUES>                             6,830,713
<CGS>                                        1,294,297
<TOTAL-COSTS>                                4,624,709
<OTHER-EXPENSES>                             3,095,156
<LOSS-PROVISION>                                26,713
<INTEREST-EXPENSE>                           (193,906)
<INCOME-PRETAX>                            (1,082,636)
<INCOME-TAX>                                   411,402
<INCOME-CONTINUING>                          (671,234)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (671,234)
<EPS-BASIC>                                     (0.13)
<EPS-DILUTED>                                   (0.13)